Eton Pharmaceutcials
ETON
41 hedge funds and large institutions have $36.6M invested in Eton Pharmaceutcials in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 2 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 2
141% more funds holding
Funds holding: 17 → 41 (+24)
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
51% more capital invested
Capital invested by funds: $24.3M → $36.6M (+$12.4M)
0.87% less ownership
Funds ownership: 33.39% → 32.52% (-0.87%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.12M |
| 2 |
State Street
Boston,
Massachusetts
|
+$749K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$526K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$374K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$241K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$1.1M |
| 2 |
AIC
AWM Investment Company
New York
|
-$1.06M |
| 3 |
PCM
Prelude Capital Management
New York
|
-$604K |
| 4 |
Renaissance Technologies
New York
|
-$149K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$24.8K |
ETON Hedge Fund Activity: Q2 2020 in Review
41 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q2 2020, worth a combined $36.6M — up 51% from $24.3M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ETON positions and 2 closed out — a net gain of 24 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $3.12M. The largest seller was Diametric Capital, cutting an estimated $1.1M.
- 41 institutional investors held Eton Pharmaceutcials (ETON) as of Q2 2020, up from 17 in Q1 2020.
- Funds reported $36.6M of Eton Pharmaceutcials stock for Q2 2020, up 51% quarter-over-quarter.
- 26 funds opened new Eton Pharmaceutcials positions in Q2 2020 and 2 closed out, a net change of +24 holders.
- The largest Eton Pharmaceutcials buyer in Q2 2020 was BlackRock, an estimated $3.12M added.
- The largest Eton Pharmaceutcials seller in Q2 2020 was Diametric Capital, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2020.